360° SearchNetwork Hot Spots Trends Time Series

Advanced Search Options >>

soft tissue sarcoma

Type: Keyphrase

Name: soft tissue sarcoma

First reported 4 hours ago - Updated 4 hours ago - 1 reports

Rick Perry

Legislative battles cease for Memorial Day service at the Capitol

AUSTIN — Clutching yellow roses, the relatives of 34 Texas servicemen and women who have died in the past two years dabbed their eyes as they listened to Gov. Rick Perry and others praise their fallen loved ones at the Legislature's Memorial Day service ... [Published MySanAntonio - 4 hours ago]

Entities: Rick Perry, War On Terror, soft tissue sarcoma

First reported May 24 2013 - Updated May 24 2013 - 1 reports

Investment Research Group

Focus turns to aldoxorubicin

May 24th 2013 - today published a report on CytRx Corporation entitled "Focus Turns To Aldoxorubicin". In summary, the report says:CytRx is now focused on fully exploiting the potential of aldoxorubicin in advanced soft tissue sarcoma (STS) following ... [Published Stockopedia - May 24 2013]

Entities: CytRx Corporation, Investment Research Group, soft tissue sarcoma

First reported May 23 2013 - Updated May 23 2013 - 1 reports

CytRx Q1 net loss decreases

3 minutes ago, 5:08am (ET) 05/23/2013 DatamonitorCytRx Corporation, a biopharmaceutical R&D company, has reported that net loss for the first quarter ended March 31, 2013 was $6.86 million, or $0.23 loss per share, compared to a net loss of $10.13 million, ... [Published Zecco - May 23 2013]

Entities: CytRx Corporation, soft tissue sarcoma, Solid Tumors

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Clifton youth team, coach go pink to fight cancer

Team's pink socks and pink beardPHOTOS COURTESY OF ANABELA CARRINO When Clifton Jr. Mustangs' lacrosse team played Wayne last week, players wore a pink sock and their coach, David Wertz, colored his beard pink to raise money for two Clifton teens diagnosed ... [Published North Jersey.com - May 22 2013]

Entities: Cancer, Hodgkin's Lymphoma, Wilson Middle School, soft tissue sarcoma

First reported May 21 2013 - Updated May 21 2013 - 1 reports

Radiation May Not Be a Breast Cancer Cure All

Italian research questions the practice of the popular post-op treatmentThe biggest challenge in treating breast cancer is finding the delicate balance between aggressively pursuing a cure and causing as little damage as possible to tender tissue so reconstruction ... [Published Prevention - May 21 2013]

Entities: Breast Cancer, Steven Chen, Radiation

First reported May 16 2013 - Updated May 16 2013 - 1 reports

ZELTIA SA : PharmaMar to present new studies with Yondelis® at ASCO

(4-traders.com)ZELTIA NEWS:PharmaMar to present new studies with Yondelis® atASCOTwo studies that will be presented are especially noteworthy, as Yondelis® was administered as first-line treatment in patients with different types of soft tissue sarco ... [Published 4 Traders - May 16 2013]

Entities: Zeltia SA, soft tissue sarcoma, Patient

First reported May 06 2013 - Updated May 07 2013 - 2 reports

Phase II

Patent Issued In China For EntreMed's Lead Drug Candidate ENMD-2076

ROCKVILLE, Md. (Logo: http://photos.prnewswire.com/prnh/20010620/ENMDLOGO )"We are very pleased with the issuance of this patent in ChinaENMD-2076 has completed and shown activity in Phase 1 clinical trials in solid tumor cancers, leukemia, multiple myeloma, ... [Published Bio-Medicine - May 06 2013]

Entities: EntreMed Inc, Patent Issued, Phase II, China

First reported May 07 2013 - Updated May 07 2013 - 2 reports

3 Healthcare Stock Stories For Monday Investment Wellness

Celgene Corporation ( NASDAQ: CELG ): Closing price $121.22Celgene Corporation’s subsidiary Celgene International Sàrl, announced Monday that statistical significance was attained for the primary endpoint of ACR 20 at week 16 for patients receiving apremilast 20 ... [Published Wall St. Cheat Sheet - May 07 2013]

Entities: doxorubicin, Phase IIb, Celgene Corporation

First reported May 03 2013 - Updated May 03 2013 - 1 reports

Clifton school has student's back

CLIFTON – When one of its students was diagnosed with an aggressive form of cancer, Woodrow Wilson Middle School banded together and surprised the unsuspecting family with numerous well-wishes and fundraisers created to help cover mounting hospital b ... [Published North Jersey.com - May 03 2013]

Entities: Wilson Middle School, Woodrow Wilson, soft tissue sarcoma

First reported May 02 2013 - Updated May 02 2013 - 1 reports

CytRx reaches agreement on SPA for Phase III sarcoma trial

CytRx Corporation, a biopharmaceutical R&D company, has reached an agreement with the FDA under a special protocol assessment, or SPA, for a global pivotal Phase III trial with aldoxorubicin as a treatment for patients with soft tissue sarcomas who have ... [Published Individual.com - May 02 2013]

Entities: CytRx Corporation, sarcoma, soft tissue sarcoma, Phase III

First reported May 02 2013 - Updated May 02 2013 - 1 reports

Soft Tissue Sarcoma - Pipeline Review, H1 2013

Global soft tissue sarcoma market: New market research published Soft Tissue Sarcoma – Pipeline Review, H1 2013 - 'Soft Tissue Sarcoma - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information ... [Published companiesandmarkets.com - May 02 2013]

Entities: soft tissue sarcoma, Therapeutics, Molecule, Mergers & Acquisitions

First reported May 02 2013 - Updated May 02 2013 - 1 reports

Report sheds light on teen, young adult cancer

More than 90 per cent of teenagers and young adults diagnosed with cancer survive for at least a year, a new report from the National Cancer Intelligence Network (NCIN) has revealed.However, the percentage of those who survive for less than 12 months ... [Published NetDoctor.co.uk - May 02 2013]

Entities: Cancer, Intelligence, Tony Moran, soft tissue sarcoma

Quotes

"We are focusing on advancing the clinical development of aldoxorubicin for the treatment of patients with soft tissue sarcoma as well as for various other indications, and expanding our oncology pipeline by combining our novel linker platform technology with additional chemotherapeutic agents" said Steven Kriegsman, CytRx president and CEO

CytRx Q1 net loss decreases [Published Zecco - May 23 2013]

"It was time to give the kids a lesson in caring for those around you," Wertz said. "They're going through something that no child should ever go through."

Clifton youth team, coach go pink to fight cancer [Published North Jersey.com - May 22 2013]

...failure and of soft tissue sarcoma," says the study's lead author, Corrado Tinterri, MD, clinical director of the Humanitas Cancer Center in Milan. "Moreover, reduced vascular supply to the breast could render reconstructive surgery in a second operation difficult."

Radiation May Not Be a Breast Cancer Cure All [Published Prevention - May 21 2013]

..."We are very pleased with the issuance of this patent in China for ENMD-2076," said Ken K Ren, Ph D , the Company's CEO. "This patent provides intellectual property protection for ENMD-2076 in a market that is experiencing tremendous growth and of which we intend to capitalize on. The issuance of this patent broadens our existing international patent estate for ENMD-2076 and also confirms the Chinese State Intellectual Property Office's recognition that ENMD-2076 represents new and inventive chemical structures."

EntreMed receives patent for cancer drug in China [Published Individual.com - May 17 2013]

More Content

sort by: Date \| Relevance
Legislative battles cease for Memorial Day serv... [Published MySanAntonio - 4 hours ago]
Focus turns to aldoxorubicin [Published Stockopedia - May 24 2013]
CytRx Q1 net loss decreases [Published Zecco - May 23 2013]
Clifton youth team, coach go pink to fight cancer [Published North Jersey.com - May 22 2013]
Radiation May Not Be a Breast Cancer Cure All [Published Prevention - May 21 2013]
EntreMed receives patent for cancer drug in China [Published Individual.com - May 17 2013]
ZELTIA SA : PharmaMar to present new studies wi... [Published 4 Traders - May 16 2013]
MOLECULAR MEDICINE SPA: MolMed clinical develop... [Published 4 Traders - May 16 2013]
BRIEF: AREA SPORTS BRIEFS: EHS softball receive... [Published Individual.com - May 15 2013]
This Stock Should Get Better in the Long Run [Published Motley Fool - May 15 2013]
EntreMed Reports First Quarter 2013 Financial R... [Published Barchart - May 15 2013]
3 Biotech Stocks With Potential [Published Seeking Alpha - May 14 2013]
FORM, MSCI, ZIOP, DFZ, GJS, ICFI Are Seasonally... [Published Individual.com - May 14 2013]
Vietnam Vets, Agent Orange and Prostate Cancer [Published Daily Rx - May 13 2013]
Tumor Grade [Published National Cancer Institute - May 10 2013]
The trauma of change and surgical upheaval [Published Irish Medical Times - May 10 2013]
CytRx Corporation Reports 2013 First Quarter Fi... [Published BioSpace - May 09 2013]
CytRx Reports 2013 First Quarter Financial Results [Published Business Wire Science: Science News - May 09 2013]
CytRx Reports 2013 First Quarter Financial Results [Published Business Wire Health News - May 09 2013]
Merck Announces FDA Acceptance of BLA for Inves... [Published BioMedReports - May 09 2013]
CytRx Provides Update on Clinical Programs [Published NewsBlaze - May 08 2013]
Zalicus Secures New $25 Million Funding Commitm... [Published NewsBlaze - May 08 2013]
CytRx Provides Update on Clinical Programs [Published Zecco - May 08 2013]
Teva and Alexza Announce Teva's License to Mark... [Published NewsBlaze - May 08 2013]
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) Investor I... [Published Prlog - May 07 2013]
ZELTIA SA: PharmaMar completes enrolment for it... [Published 4 Traders - May 07 2013]
3 Healthcare Stock Stories For Monday Investmen... [Published Wall St. Cheat Sheet - May 07 2013]
3 Healthcare Stock Stories For Monday Investmen... [Published Wall St. Cheat Sheet - May 07 2013]
CytRx Receives Recommendation for Aldoxorubicin... [Published BioMedReports - May 07 2013]
Martin, Joseph A. "Joe" [Published Capital Times - May 06 2013]

Blogs

sort by: Date \| Relevance
3 Healthcare Stock Stories For Monday Investmen... [Published Wall St. Cheat Sheet - May 07 2013] Celgene Corporation ( NASDAQ: CELG ): Closing price $121.22Celgene Corporation’s subsidiary Celgene International Sàrl, announced Monday that statistical significance was attained for the primary endpoint of ACR 20 at week 16 for patients receiving apremilast 20 ...
3 Healthcare Stock Stories For Monday Investmen... [Published Wall St. Cheat Sheet - May 07 2013] Celgene Corporation ( NASDAQ: CELG ): Closing price $121.22 Celgene Corporation’s subsidiary Celgene International Sàrl, announced Monday that statistical significance was attained for the primary endpoint of ACR 20 at week 16 for patients receiving apremilast 20 ...
4 Healthcare Stock Stories for Wednesday Invest... [Published Wall St. Cheat Sheet - Mar 27 2013] Pfizer ( NYSE:PFE ): Current price $28.63 In the United Kingdom, the National Institute for Health and Clinical Excellence decided Wednesday that Pfizer’s new lung cancer pill Xalkori costs too much to be worth using on Britain’s state health service. ...
BlackBerry Demand Won’t Be Sustained and 2 Othe... [Published Wall St. Cheat Sheet - Mar 26 2013] Ziopharm Oncology ( NASDAQ:ZIOP ): Current price $1.98 Ziopharm Oncology’s most advanced product, the potential cancer treatment palifosfamide, failed in a late-stage evaluation. The firm also said that it would immediately switch its strategic concentration ...
Pfizer Drug Gets Approval and 2 Hot Stocks to W... [Published Wall St. Cheat Sheet - Mar 26 2013] Ziopharm Oncology ( NASDAQ:ZIOP ): The company saw a sharp decline during premarket trading on Tuesday after the drug developer announced that its most advanced product, the potential cancer treatment palifosfamide, failed in a late-stage study, Associated ...

Press Releases

sort by: Date \| Relevance
CytRx Reports 2013 First Quarter Financial Results [Published Business Wire Science: Science News - May 09 2013]
CytRx Reports 2013 First Quarter Financial Results [Published Business Wire Health News - May 09 2013]
CytRx Receives Recommendation from Data Safety ... [Published Business Wire Health News - May 06 2013]
Patent Issued In U.S. For EntreMed's 2ME2 In Rh... [Published PR Newswire - May 03 2013]
CytRx Announces Agreement with FDA on Special P... [Published Business Wire Science: Science News - Apr 23 2013]